{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:32:00Z","timestamp":1789687920277,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier","isbn-type":[{"value":"9780128215869","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.pbr.2020.12.004","type":"book-chapter","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T07:53:32Z","timestamp":1611129212000},"page":"423-440","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy and safety of single- and repeated-selurampanel dosing for 2 weeks in patients with chronic subjective tinnitus: Results of a randomized, double-blind, placebo-controlled, cross-over, proof-of-concept phase IIa study"],"prefix":"10.1016","member":"78","reference":[{"issue":"2","key":"10.1016\/bs.pbr.2020.12.004_bb0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1044\/1059-0889(2012\/12-0010)","article-title":"Psychometric evaluation of visual analog scale for the assessment of chronic tinnitus","volume":"21","author":"Adamchic","year":"2012","journal-title":"Am. J. Audiol."},{"key":"10.1016\/bs.pbr.2020.12.004_bb0015","series-title":"21st International Symposium on Medicinal Chemistry, 5\u20139 September, 2010","article-title":"BGG492, a competitive AMPA\/kainate antagonist in clinical development for the treatment of migraine and epilepsy [abstract]. Presented at the European Federation for Medicinal Chemistry","author":"Auberson","year":"2010"},{"issue":"9","key":"10.1016\/bs.pbr.2020.12.004_bb0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/14992027.2011.653448","article-title":"Validation of the THI-12 questionnaire for international use in assessing tinnitus: a multi-centre, prospective, observational study","volume":"51","author":"Bankstahl","year":"2012","journal-title":"Int. J. Audiol."},{"key":"10.1016\/bs.pbr.2020.12.004_bb9000","series-title":"Fycompa\u2122 (Perampanel) Summary of Product Characteristics","author":"Eisai Inc","year":"2017"},{"key":"10.1016\/bs.pbr.2020.12.004_bb9005","series-title":"Fycompa\u2122 (Perampanel) Prescribing Information","author":"Eisai Inc","year":"2020"},{"issue":"10","key":"10.1016\/bs.pbr.2020.12.004_bb0025","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nrn4003","article-title":"Tinnitus: perspectives from human neuroimaging","volume":"16","author":"Elgoyhen","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/bs.pbr.2020.12.004_bb0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1517\/13543784.2014.848854","article-title":"BGG492 (selurampanel), an AMPA\/kainate receptor antagonist drug for epilepsy","volume":"23","author":"Faught","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/bs.pbr.2020.12.004_bb0035","article-title":"Cognitive behavioural therapy for tinnitus","author":"Fuller","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/bs.pbr.2020.12.004_bb0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000431376","article-title":"Prevalence and determinants of tinnitus in the Italian adult population","volume":"45","author":"Gallus","year":"2015","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/bs.pbr.2020.12.004_bb0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0333102413499648","article-title":"Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks","volume":"34","author":"Gomez-Mancilla","year":"2014","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/bs.pbr.2020.12.004_bb0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/14992027.2011.578591","article-title":"Assessment of tinnitus-related impairments and disabilities using the German THI-12: sensitivity and stability of the scale over time","volume":"50","author":"G\u00f6rtelmeyer","year":"2011","journal-title":"Int. J. Audiol."},{"key":"10.1016\/bs.pbr.2020.12.004_bb0055","first-page":"39","article-title":"Der Tinnitus-Beeintr\u00e4chtigungsfragebogen (TBF-12): Uebersetzung und Adaptation","volume":"21","author":"Greimel","year":"2000","journal-title":"Verhaltenstherapie Verhaltensmedizin"},{"issue":"1","key":"10.1016\/bs.pbr.2020.12.004_bb0060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13063-016-1399-9","article-title":"Systematic review of outcome domains and instruments used in clinical trials of tinnitus treatments in adults","volume":"17","author":"Hall","year":"2016","journal-title":"Trials"},{"issue":"10","key":"10.1016\/bs.pbr.2020.12.004_bb0065","article-title":"Glutamate receptor antagonists for tinnitus","author":"Imsuwansri","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/bs.pbr.2020.12.004_bb0070","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/epi.13008","article-title":"Dose-dependent suppression of human photoparoxysmal response with the competitive AMPA\/kainate receptor antagonist BGG492: clear PK\/PD relationship","volume":"56","author":"Kasteleijn-Nolst Trenit\u00e9","year":"2015","journal-title":"Epilepsia"},{"issue":"17","key":"10.1016\/bs.pbr.2020.12.004_bb0075","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1517\/14656566.2012.739608","article-title":"Current pharmacological treatments for tinnitus","volume":"13","author":"Langguth","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/bs.pbr.2020.12.004_bb0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-pharmtox-010818-021556","article-title":"Therapeutic approaches to the treatment of tinnitus","volume":"59","author":"Langguth","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/bs.pbr.2020.12.004_bb0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fneur.2014.00227","article-title":"Cochlear damage affects neurotransmitter chemistry in the central auditory system","volume":"5","author":"Lee","year":"2014","journal-title":"Front. Neurol."},{"issue":"1\u20132","key":"10.1016\/bs.pbr.2020.12.004_bb0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5955(03)00225-9","article-title":"Changes in spontaneous neural activity immediately after an acoustic trauma: implications for neural correlates of tinnitus","volume":"183","author":"Nore\u00f1a","year":"2003","journal-title":"Hear. Res."},{"issue":"3","key":"10.1016\/bs.pbr.2020.12.004_bb0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/cmdc.201600467","article-title":"Design and synthesis of selurampanel, a novel orally active and competitive AMPA receptor antagonist","volume":"12","author":"Orain","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/bs.pbr.2020.12.004_bb0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5698\/1535-7511-11.2.56","article-title":"Revisiting AMPA receptors as an antiepileptic drug target","volume":"11","author":"Rogawski","year":"2011","journal-title":"Epilep. Curr."},{"issue":"5","key":"10.1016\/bs.pbr.2020.12.004_bb0105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1358\/dof.2009.34.5.1362442","article-title":"Pharmacological treatments for tinnitus: new and old","volume":"34","author":"Salvi","year":"2009","journal-title":"Drugs Future"},{"issue":"3","key":"10.1016\/bs.pbr.2020.12.004_bb0110","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrneurol.2016.12","article-title":"Maladaptive plasticity in tinnitus\u2013triggers, mechanisms and treatment","volume":"12","author":"Shore","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/bs.pbr.2020.12.004_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6815-11-1","article-title":"A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus","volume":"11","author":"Suckf\u00fcll","year":"2011","journal-title":"BMC Ear Nose Throat Disord."},{"issue":"3","key":"10.1016\/bs.pbr.2020.12.004_bb0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jfma.2015.11.011","article-title":"Tinnitus and its current treatment--still an enigma in medicine","volume":"115","author":"Swain","year":"2016","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/bs.pbr.2020.12.004_bb0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.neuroscience.2008.02.066","article-title":"Kainate receptors in epilepsy and excitotoxicity","volume":"158","author":"Vincent","year":"2009","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/bs.pbr.2020.12.004_bb0130","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/0194599811403882","article-title":"Tinnitus handicap inventory for evaluating treatment effects: which changes are clinically relevant?","volume":"145","author":"Zeman","year":"2011","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/bs.pbr.2020.12.004_bb0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1477-7525-10-128","article-title":"Tinnitus assessment by means of standardized self-report questionnaires: psychometric properties of the Tinnitus Questionnaire (TQ), the Tinnitus Handicap Inventory (THI), and their short versions in an international and multi-lingual sample","volume":"10","author":"Zeman","year":"2012","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/bs.pbr.2020.12.004_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7525-12-7","article-title":"Which tinnitus-related aspects are relevant for quality of life and depression: results from a large international multicentre sample","volume":"12","author":"Zeman","year":"2014","journal-title":"Health Qual. Life Outcomes"}],"container-title":["Progress in Brain Research","Tinnitus - An Interdisciplinary Approach Towards Individualized Treatment: From Heterogeneity to Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007961232030234X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007961232030234X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T22:02:21Z","timestamp":1758751341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S007961232030234X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128215869"],"references-count":29,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2020.12.004","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}